Market revenue in 2024 | USD 7.7 million |
Market revenue in 2030 | USD 16.1 million |
Growth rate | 13% (CAGR from 2025 to 2030) |
Largest segment | Implanted heart pump devices |
Fastest growing segment | Extracorporeal Heart Pump Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Implanted Heart Pump Devices, Extracorporeal Heart Pump Devices |
Key market players worldwide | Abbott Laboratories, Johnson & Johnson, Getinge AB ADR, LivaNova PLC, Teleflex Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart pump device market will help companies and investors design strategic landscapes.
Implanted heart pump devices was the largest segment with a revenue share of 75.32% in 2024. Horizon Databook has segmented the Argentina heart pump device market based on implanted heart pump devices, extracorporeal heart pump devices covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina heart pump device market , including forecasts for subscribers. This country databook contains high-level insights into Argentina heart pump device market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account